CaringBand is using a simple technology to better connect family and friends to the ones they love. Courtesy of CaringBand

When Charley Donaldson's mother-in-law was battling cancer, he and his wife had great support from their friends and family. But they also knew there were a lot of people who cared about them who didn't know what to say or do during such a challenging time.

"It's like, you want to show people that you care about them, but you don't want to interrupt their day, or you don't want to be a burden to them if they aren't up to company," Donaldson says about the common reactions he heard from others – and often felt himself when he had friends going through similar struggles. "There had to be a way to share the idea of, 'Hey, I'm thinking about you.'"

It took three years of rattling around that idea before CaringBand came to life. The light-up bracelet is Bluetooth enabled, and connects to a mobile app. A person gives the bracelet to a loved one, who then pairs it with his or her smartphone. App users can send and receive pre-set messages of encouragement to and from other app users.

Those wearing a CaringBand bracelet get alerted by a blinking light or vibration that lets them know someone is thinking about them. The wearer then reads these encouraging messages on the CaringBand app when convenient and with no need to respond.

"When we pilot tested it, we were super excited to find out what we thought was validated," says Donaldson. "People really loved knowing that others were keeping them in their thoughts, and those who sent messages liked that they didn't have to worry about saying or doing the wrong thing."

Donaldson says he wanted The CaringBand to be as easy as possible for people to use, and also ensure that it was a solid support system. When someone is going through medical treatments, he knows that can be exhausting, and he also realizes that friends and family want to be able to do something, anything, to express their love and support.

"If you're a normal, compassionate person, you want to show you care about someone," he says. "This lets you do that in your own way."

And while it might sound like The CaringBand is designed to make the senders of messages feel better about offering a good thought for someone, Donaldson says those going through treatments have really loved seeing their bracelets light to up to tell them they're on someone's mind. That small show of support has made a big difference, they told Donaldson in surveys.

"She is sitting on the couch having so much fun reading her messages," says one user in a testimonial. "The smile on her face is priceless." "People tell you they think of you and pray for you all the time," read another. "The bracelet gives you a reminder that they really are."

"We made it super easy," he says. "It's a hardware to software solution and we wanted to erase as many friction points as possible in its creation. This is two touches of a smart phone."

Currently, the CaringBand app is live and functional. The bracelet is still in developmental stages, and Donaldson says the team is working with individuals and groups such as the Tyler Robinson Foundation to further test it. The bracelet should be a go for full distribution and sale by the first quarter of 2020.

"Obviously, this doesn't replace driving over to see someone or having a cup of coffee with a friend," says Donaldson. "But it is a great supplemental tool to show your love and care when you might not know what else to do."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Biosciences startup becomes Texas' first decacorn after latest funding

A Dallas-based biosciences startup whose backers include millionaire investors from Austin and Dallas has reached decacorn status — a valuation of at least $10 billion — after hauling in a series C funding round of $200 million, the company announced this month. Colossal Biosciences is reportedly the first Texas startup to rise to the decacorn level.

Colossal, which specializes in genetic engineering technology designed to bring back or protect various species, received the $200 million from TWG Global, an investment conglomerate led by billionaire investors Mark Walter and Thomas Tull. Walter is part owner of Major League Baseball’s Los Angeles Dodgers, and Tull is part owner of the NFL’s Pittsburgh Steelers.

Among the projects Colossal is tackling is the resurrection of three extinct animals — the dodo bird, Tasmanian tiger and woolly mammoth — through the use of DNA and genomics.

The latest round of funding values Colossal at $10.2 billion. Since launching in 2021, the startup has raised $435 million in venture capital.

In addition to Walter and Tull, Colossal’s investors include prominent video game developer Richard Garriott of Austin and private equity veteran Victor Vescov of Dallas. The two millionaires are known for their exploits as undersea explorers and tourist astronauts.

Aside from Colossal’s ties to Dallas and Austin, the startup has a Houston connection.

The company teamed up with Baylor College of Medicine researcher Paul Ling to develop a vaccine for elephant endotheliotropic herpesvirus (EEHV), the deadliest disease among young elephants. In partnership with the Houston Zoo, Ling’s lab at the Baylor College of Medicine has set up a research program that focuses on diagnosing and treating EEHV, and on coming up with a vaccine to protect elephants against the disease. Ling and the BCMe are members of the North American EEHV Advisory Group.

Colossal operates research labs Dallas, Boston and Melbourne, Australia.

“Colossal is the leading company working at the intersection of AI, computational biology, and genetic engineering for both de-extinction and species preservation,” Walter, CEO of TWG Globa, said in a news release. “Colossal has assembled a world-class team that has already driven, in a short period of time, significant technology innovations and impact in advancing conservation, which is a core value of TWG Global.”

Well-known genetics researcher George Church, co-founder of Colossal, calls the startup “a revolutionary genetics company making science fiction into science fact.”

“We are creating the technology to build de-extinction science and scale conservation biology,” he added, “particularly for endangered and at-risk species.”

Houston investment firm names tech exec as new partner

new hire

Houston tech executive Robert Kester has joined Houston-based Veriten, an energy-focused research, investment and strategy firm, as technology and innovation partner.

Kester most recently served as chief technology officer for emissions solutions at Honeywell Process Solutions, where he worked for five years. Honeywell International acquired Houston-based oil and gas technology company Rebellion Photonics, where Kester was co-founder and CEO, in 2019.

Honeywell Process Solutions shares offices in Houston with the global headquarters of Honeywell Performance Materials and Technologies. Honeywell, a Fortune 100 conglomerate, employs more than 850 people in Houston.

“We are thrilled to welcome Robert to the Veriten team,” founder and CEO Maynard Holt said in a statement, “and are confident that his technical expertise and skills will make a big contribution to Veriten’s partner and investor community. He will [oversee] every aspect of what we do, with the use case for AI in energy high on the 2025 priority list.”

Kester earned a doctoral degree in bioengineering from Rice University, a master’s degree in optical sciences from the University of Arizona and a bachelor’s degree in laser optical engineering technology from the Oregon Institute of Technology. He holds 25 patents and has more than 25 patents pending.

Veriten celebrated its third anniversary on January 10, the day that the hiring of Kester was announced. The startup launched with seven employees.

“With the addition of Dr. Kester, we are a 26-person team and are as enthusiastic as ever about improving the energy dialogue and researching the future paths for energy,” Holt added.

Kester spoke on the Houston Innovators Podcast in 2021. Listen here

.